Delivery Order SPE2DB22D9367-SPE2DB24FSV82
Award Date
1/23/24
Potential Completion Date
2/13/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563401429 - SKYLA 13.5 MG SYSTEMS. The $3,295.25 delivery order has a completion date of February 5, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various indefinite delivery contracts with the Defense Logistics Agency to supply pharmaceuticals and medical products to military treatment facilities globally. This...
This is a $1,822.36 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business. The delivery order is for the supply of a pharmaceutical product called SKYLA 13.5 MG SYSTEMS. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA to provide various medical supplies and pharmaceutical items to military treatment facilities worldwide. This specific delivery order is not associated...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the SKYLA 13.5 MG SYSTEMS medical device. The $9,415.00 contract has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription drugs, over-the-counter products, and medical supplies to support military treatment facilities worldwide under various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of SKYLA 13.5 MG SYSTEMS. The contract has a ceiling value of $9,415.00 and a period of performance through April 11, 2024. This delivery order is placed against a larger indefinite delivery contract, SPE2DB, held by DMS Pharmaceutical Group with DLA, valued up to $4,999,999 through the end of 2025. The SPE2DB contract enables DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,270.95, is for the delivery of SKYLA 13.5 MG SYSTEMS, a pharmaceutical product, with a performance period through May 13, 2024. The contract is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, under the SPE2DB...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on September 26, 2024. The contract, which has a ceiling value of $1,412.25, is for the delivery of SKYLA 13.5 MG SYSTEMS and has an ultimate completion date of October 18, 2024. The contract is not set aside for any specific small business program. This delivery order is part of a larger indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,822.36 contract is for the delivery of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product, with a performance period through March 16, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,644.72 firm fixed-price delivery order is for the procurement of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. The delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,353.75, is for the supply of the pharmaceutical product SKYLA 13.5 MG SYSTEMS. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,236.75, is for the delivery of Skyla 13.5 mg systems, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...